Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Training health care providers to provide PrEP for HIV serodiscordant couples attending public health facilities in Kenya.

Irungu EM, Ngure K, Mugwanya K, Mugo N, Bukusi E, Wamoni E, Odoyo J, Morton JF, Bernabee G, Mambo B, Masyuko S, Mukui I, O'Malley G, Baeten JM.

Glob Public Health. 2019 Mar 14:1-11. doi: 10.1080/17441692.2019.1588908. [Epub ahead of print]

PMID:
30871413
2.

Pre-exposure prophylaxis rollout in a national public sector program: the Kenyan case study.

Masyuko S, Mukui I, Njathi O, Kimani M, Oluoch P, Wamicwe J, Mutegi J, Njogo S, Anyona M, Muchiri P, Maikweki L, Musyoki H, Bahati P, Kyongo J, Marwa T, Irungu E, Kiragu M, Kioko U, Ogando J, Were D, Bartilol K, Sirengo M, Mugo N, Baeten JM, Cherutich P, PrEP Technical Working Group OBOT.

Sex Health. 2018 Nov;15(6):578-586. doi: 10.1071/SH18090.

PMID:
30408432
3.

ScaleĀ up of PrEP integrated in public health HIV care clinics: a protocol for a stepped-wedge cluster-randomized rollout in Kenya.

Mugwanya KK, Irungu E, Bukusi E, Mugo NR, Odoyo J, Wamoni E, Ngure K, Morton JF, Peebles K, Masyuko S, Barnabee G, Donnell D, Barnabas R, Haberer J, O'Malley G, Baeten JM; Partners Scale Up Team.

Implement Sci. 2018 Sep 4;13(1):118. doi: 10.1186/s13012-018-0809-7.

4.

Effect of Depression on Adherence to Oral PrEP Among Men and Women in East Africa.

Velloza J, Baeten JM, Haberer J, Ngure K, Irungu E, Mugo NR, Celum C, Heffron R; Partners Demonstration Project Team.

J Acquir Immune Defic Syndr. 2018 Nov 1;79(3):330-338. doi: 10.1097/QAI.0000000000001821.

5.

Depression and ART Initiation Among HIV Serodiscordant Couples in Kenya and Uganda.

Velloza J, Celum C, Haberer JE, Ngure K, Irungu E, Mugo N, Baeten JM, Heffron R; Partners Demonstration Project Team.

AIDS Behav. 2017 Aug;21(8):2509-2518. doi: 10.1007/s10461-017-1829-z.

6.

Feasibility and acceptability of HIV self-testing among pre-exposure prophylaxis users in Kenya.

Ngure K, Heffron R, Mugo N, Thomson KA, Irungu E, Njuguna N, Mwaniki L, Celum C, Baeten JM.

J Int AIDS Soc. 2017 Feb 10;20(1):21234. doi: 10.7448/IAS.20.1.21234.

7.

Correction for Lund et al., HIV-1-Neutralizing IgA Detected in Genital Secretions of Highly HIV-1-Exposed Seronegative Women on Oral Preexposure Prophylaxis.

Lund JM, Broliden K, Pyra MN, Thomas KK, Donnell D, Irungu E, Muwonge TR, Mugo N, Manohar M, Jansson M, Mackelprang R, Marzinke MA, Baeten JM, Lingappa JR.

J Virol. 2017 Jan 18;91(3). pii: e02074-16. doi: 10.1128/JVI.02074-16. Print 2017 Feb 1. No abstract available.

8.

Use of a risk scoring tool to identify higher-risk HIV-1 serodiscordant couples for an antiretroviral-based HIV-1 prevention intervention.

Irungu EM, Heffron R, Mugo N, Ngure K, Katabira E, Bulya N, Bukusi E, Odoyo J, Asiimwe S, Tindimwebwa E, Celum C, Baeten JM; Partners Demonstration Project Team.

BMC Infect Dis. 2016 Oct 17;16(1):571.

9.

HIV-1-Neutralizing IgA Detected in Genital Secretions of Highly HIV-1-Exposed Seronegative Women on Oral Preexposure Prophylaxis.

Lund JM, Broliden K, Pyra MN, Thomas KK, Donnell D, Irungu E, Muwonge TR, Mugo N, Manohar M, Jansson M, Mackelprang R, Marzinke MA, Baeten JM, Lingappa JR.

J Virol. 2016 Oct 14;90(21):9855-9861. doi: 10.1128/JVI.01482-16. Print 2016 Nov 1. Erratum in: J Virol. 2017 Jan 18;91(3):.

10.

Intimate Partner Violence and Adherence to HIV Pre-exposure Prophylaxis (PrEP) in African Women in HIV Serodiscordant Relationships: A Prospective Cohort Study.

Roberts ST, Haberer J, Celum C, Mugo N, Ware NC, Cohen CR, Tappero JW, Kiarie J, Ronald A, Mujugira A, Tumwesigye E, Were E, Irungu E, Baeten JM; Partners PrEP Study Team.

J Acquir Immune Defic Syndr. 2016 Nov 1;73(3):313-322.

11.

The Effect of Human Immunodeficiency Virus Prevention and Reproductive Health Text Messages on Human Immunodeficiency Virus Testing Among Young Women in Rural Kenya: A Pilot Study.

Njuguna N, Ngure K, Mugo N, Sambu C, Sianyo C, Gakuo S, Irungu E, Baeten J, Heffron R.

Sex Transm Dis. 2016 Jun;43(6):353-9. doi: 10.1097/OLQ.0000000000000450.

12.

The preexposure prophylaxis revolution; from clinical trials to programmatic implementation.

Mugo NR, Ngure K, Kiragu M, Irungu E, Kilonzo N.

Curr Opin HIV AIDS. 2016 Jan;11(1):80-6. doi: 10.1097/COH.0000000000000224. Review.

13.

Mannose-binding lectin and ficolin-2 do not influence humoral immune response to hepatitis B vaccine.

Osthoff M, Irungu E, Ngure K, Mugo N, Thomas KK, Baeten JM, Eisen DP.

Vaccine. 2014 Aug 20;32(37):4772-7. doi: 10.1016/j.vaccine.2014.06.023. Epub 2014 Jul 10.

14.

Immune response to hepatitis B virus vaccination among HIV-1 infected and uninfected adults in Kenya.

Irungu E, Mugo N, Ngure K, Njuguna R, Celum C, Farquhar C, Dhanireddy S, Baeten JM.

J Infect Dis. 2013 Feb 1;207(3):402-10. doi: 10.1093/infdis/jis695. Epub 2012 Nov 21.

15.

Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.

Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, Tappero JW, Bukusi EA, Cohen CR, Katabira E, Ronald A, Tumwesigye E, Were E, Fife KH, Kiarie J, Farquhar C, John-Stewart G, Kakia A, Odoyo J, Mucunguzi A, Nakku-Joloba E, Twesigye R, Ngure K, Apaka C, Tamooh H, Gabona F, Mujugira A, Panteleeff D, Thomas KK, Kidoguchi L, Krows M, Revall J, Morrison S, Haugen H, Emmanuel-Ogier M, Ondrejcek L, Coombs RW, Frenkel L, Hendrix C, Bumpus NN, Bangsberg D, Haberer JE, Stevens WS, Lingappa JR, Celum C; Partners PrEP Study Team.

N Engl J Med. 2012 Aug 2;367(5):399-410. doi: 10.1056/NEJMoa1108524. Epub 2012 Jul 11.

16.

High-dose valacyclovir HSV-2 suppression results in greater reduction in plasma HIV-1 levels compared with standard dose acyclovir among HIV-1/HSV-2 coinfected persons: a randomized, crossover trial.

Mugwanya K, Baeten JM, Mugo NR, Irungu E, Ngure K, Celum C.

J Infect Dis. 2011 Dec 15;204(12):1912-7. doi: 10.1093/infdis/jir649. Epub 2011 Oct 12.

17.

Successful increase in contraceptive uptake among Kenyan HIV-1-serodiscordant couples enrolled in an HIV-1 prevention trial.

Ngure K, Heffron R, Mugo N, Irungu E, Celum C, Baeten JM.

AIDS. 2009 Nov;23 Suppl 1:S89-95. doi: 10.1097/01.aids.0000363781.50580.03.

18.

Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.

Celum C, Wald A, Lingappa JR, Magaret AS, Wang RS, Mugo N, Mujugira A, Baeten JM, Mullins JI, Hughes JP, Bukusi EA, Cohen CR, Katabira E, Ronald A, Kiarie J, Farquhar C, Stewart GJ, Makhema J, Essex M, Were E, Fife KH, de Bruyn G, Gray GE, McIntyre JA, Manongi R, Kapiga S, Coetzee D, Allen S, Inambao M, Kayitenkore K, Karita E, Kanweka W, Delany S, Rees H, Vwalika B, Stevens W, Campbell MS, Thomas KK, Coombs RW, Morrow R, Whittington WL, McElrath MJ, Barnes L, Ridzon R, Corey L; Partners in Prevention HSV/HIV Transmission Study Team.

N Engl J Med. 2010 Feb 4;362(5):427-39. doi: 10.1056/NEJMoa0904849. Epub 2010 Jan 20.

Supplemental Content

Loading ...
Support Center